Cardiac resynchronization therapy defibrillator implantation conferred improved outcomes vs. implantable cardioverter defibrillator implantation in patients without left bundle branch block, ...

February 4, 2004 — Is it time to redefine the role of QRS duration as a predictor of response to cardiac resynchronization therapy (CRT)? According to 2 recent studies published in the Journal of the ...

Among patients with a wide QRS, cardiac resynchronization therapy (CRT) seems to help patients with an intraventricular conduction delay (IVCD) as much as it does those with left bundle branch block ...

There are 4.8 million patients with congestive heart failure (CHF) in the United States as of 2002, with an additional 400,000-700,000 new cases presenting each year. CHF remains the most frequent ...

This page lists all known medications that could potentially lead to 'Defect conduction intraventricular' as a side effect. It's important to note that mild side effects are quite common with ...

Cardiac resynchronization therapy with defibrillator (CRT-D) can help certain patients with non-left bundle branch block (non-LBBB) with heart failure if traditional, implantable cardioverter ...

In patients undergoing TAVR with Sapien 3, implantation depth and prosthesis oversizing are strongly correlated with the occurrence of new conduction abnormalities and/or permanent pacemaker ...

Lead augmented vector right (aVR) is a useful measure in the diagnosis of ST-segment elevation acute myocardial infarction (STEMI), indicates a new analysis of data from the HERO-2 trial. “Lead aVR is ...

A 58-year-old man presented to the emergency department with a two-week history of crescendo angina. Initial physical examination, biomarkers and an electrocardiogram (ECG) were unremarkable. While ...

The interventricular septum separates the heart’s two ventricles and plays a vital role in maintaining correct bloodflow. Sometimes a defect can occur or be present from birth. This can increase the ...